67.11 KWD
Wegovy FlexTouch 2.4mg Solution for Injection in Pre-filled Pen (3ml)
Ozempic 0.5 mg Solution for Injection in Pre-filled Pen (Once weekly) (1.5 ml)
Wegovy FlexTouch 0.25 mg (Semaglutide) Pre-Filled Pen
Wegovy FlexTouch 1.7 mg Solution for Injection in Pre-filled Pen (3 ml) is a prescription medication used for weight management in adults with obesity or overweight who have at least one weight-related health condition. It contains semaglutide, a GLP-1 analogue, and is given as a once-weekly subcutaneous injection.
Semaglutide 2.27 mg/mL
Each pre-filled pen contains 6.8 mg semaglutide in 3 mL solution, delivering four weekly doses of 1.7 mg each.
Used alongside a reduced-calorie diet and increased physical activity for weight management in adults with:
BMI ≥30 kg/m² (obesity)
BMI ≥27 kg/m² (overweight) with at least one weight-related comorbidity (such as hypertension, type 2 diabetes, or dyslipidemia)
Inject 1.7 mg subcutaneously once weekly, on the same day each week
Each FlexTouch pen provides four weekly doses; use a new needle for each injection
Injection sites: abdomen, thigh, or upper arm
Not recommended for people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
Use caution in patients with a history of pancreatitis, diabetic retinopathy, or severe gastrointestinal disease
Inform your doctor if you are taking other diabetes medications
Nausea, vomiting, diarrhea, constipation, abdominal pain, headache
Side effects are most common at the start of treatment and usually decrease over time
Store in a refrigerator (2°C–8°C). Do not freeze
After first use, the pen can be kept at room temperature (below 30°C) for up to 6 weeks
Keep out of reach of children
